[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

BEKhealth Raises $4 Million to Fuel Expansion Following Strong Customer Growth in 2024

BEKhealth

BEKhealth brings an innovative AI-driven technology to transform and organize electronic health records (EHR), providing a scalable clinical data platform that optimizes performance for research networks, biopharma, and contract research organizations.

BEKhealth, an AI-powered chart abstraction and patient-matching platform company, announced today it raised $4 million to support its continued growth. This latest financing was co-led by Hatteras Venture Partners and Boston Millennia Partners with participation from existing investors Excelerate Health Ventures, Martin Ventures; and new investors RTI International and WakeMed Innovation Fund.

Today’s announcement follows strong customer growth in 2024, during which the company expanded its customer base, which now includes Avacare Clinical Research Network, Biopharma Informatics, Chemidox, Elixia Health, Gadolin Research, Innovo Research, Javara, Om Research, Prolerity Clinical Research, Rocket Trials, Sitebridge Research, Summit Clinical Research, Tekton Research, Velocity Clinical Research, and many more. BEKhealth brings an innovative AI-driven technology that integrates electronic health records (EHR) data to optimize population feasibility and rapidly identify clinically qualified participants for clinical research. The company plans to use this most recent round of capital to continue expanding its customer base and product offering.

Related Posts
1 of 42,284

Read More on AiThority Interviews : AiThority Interview with Jeff Geiser, VP of Customer Experience at Zenlayer

“Research networks and drug developers that put the patient first will thrive in an industry that demands better designed trials, more qualified patients, and accelerated research access and enrollment. We look forward to working with the BEKhealth team as they scale their platform and services to meet a rapidly emerging and vital market opportunity,” said John Crumpler, General Partner, Hatteras Venture Partners.

Kelly Hollis, senior vice president, patient centered outcomes research at RTI Health Solutions, added, “Our investment and collaboration with BEKhealth will enable RTI to efficiently identify the right patients and gather deeper insights through integrated evidence generation across multiple data sources. Through this partnership, RTI will be able to connect real-time, real-world data with patient-provided insights to illuminate the full picture of the patient experience and patient journey with the goal of improving healthcare decision making.”

Catch more AiThority InsightsAiThority Interview with Fred Laluyaux, Co-Founder & CEO, Aera Technology

[To share your insights with us, please write to psen@itechseries.com ]

Comments are closed.